Global Conjugate Vaccines Market (2017 - 2022)

Publisher Name :
Date: 15-Mar-2019
No. of pages: 100

The market for conjugate vaccines is expected to increase, owing to global awareness about the benefits of vaccination for the prevention of certain life-threatening diseases, growing initiatives for production of low-cost vaccines, and widespread routine vaccination programmes in emerging economies. The market will witness a steady growth, expanding at a compound annual growth rate (CAGR) of 11.7% during 2017-2022, to reach approximately USD 87.7 Bn by 2022.

Disease indication segment insights:

Pneumococcal conjugate vaccine (PCV) held the largest market share (24.66%) in 2017 owing to the widespread nature of pneumococcal disease. Also, the leading vaccine-preventable cause of death among children around the world is the pneumococcal disease. Global initiatives were undertaken to speed up the introduction of pneumococcal vaccinations in low-income countries through partnerships among countries, donors, academia, international organizations, and industries. Close on its heels, the diphtheria and tetanus toxoids and pertussis (DTP) conjugate vaccine occupied a share of 23% in 2017. The higher prevalence of respiratory diseases such as whooping cough, among both children and adults, have led to the increased adoption of DTP conjugate vaccines. Haemophilus influenzae type b (Hib) conjugate vaccines are expected to grow at the fastest rate during 2017-2022.

End user segment insights:

The adult segment registered higher market share than the paediatric segment because of an increase in awareness on conjugate vaccines for adults, over the years. Still, the penetration level for adult conjugate vaccines is comparatively lower, with the lowest being for PCVs. Hence, the growth potential is very high. The paediatric vaccines, on the other hand is a stable market and depends highly on the birth rates in each region. The vaccination programmes, especially taken up by global organizations such as the United Nations Educational, Scientific and Cultural Organization (UNESCO), have been successful in eradicating many such vaccine-preventable diseases.

Regional insights:

Asia-Pacific is the largest market for conjugate vaccines, which held a share of 42%, in 2017. The primary indicators of the potential for the vaccine market is the geriatric population in the region, especially in countries such as India and China. In turn, this has, encouraged market participants to increase spending on research and development (R&D) and distribution facilities in the these countries. North America is the second biggest market for conjugate vaccines, owing to the region's widespread immunization programmes. The Middle East and Africa, and Latin America regions lack proper infrastructure and awareness of vaccine-preventable diseases, which are hindering market growth.

Companies covered:

1. GlaxoSmithKline

2. Pfizer Inc.

3. Merck & Co.

4. Novartis

5. Sanofi Pasteur

6. CSL Limited

7. Bharat Biotech International

8. Biological E Limited

9. Serum Institute of India

Customizations available

With the given market data, Netscribes offers customizations according to specific needs. Write to us at support@researchonglobalmarkets.com, or connect with us here.

Global Conjugate Vaccines Market (2017 - 2022)

Table of Contents

Chapter 1. Executive summary
1.1. Market scope and segmentation
1.2. Key questions answered
1.3. Executive summary

Chapter 2. Global conjugate vaccine market - overview
2.1. Market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), geography-wise market revenue (USD Bn), and market attractiveness analysis
2.2. Market drivers
2.3. Market trends
2.4. Market challenges
2.5. Value chain analysis
2.6. Porter's five forces analysis
2.7. Segmentation based on disease indication (pneumococcal conugate vaccine (PCV), haemophilus influenzae type B (Hib) conjugate vaccine, diptheria, tetanus toxoids and pertussis (DTP) conjugate vaccine, meningococcal conjugate vaccine, and others) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
2.8. Segmentation based on end user (pediatric vaccine, and adult vaccine) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

Chapter 3. North America conjugate vaccine market
3.1. Regional market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
3.2. Segmentation based on disease indication (pneumococcal conugate vaccine [PCV], haemophilus influenzae type B [Hib] conjugate vaccine, diptheria and tetanus toxoids and pertussis [DTP] conjugate vaccine, meningococcal conjugate vaccine, and others) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
3.3. Segmentation based on end user (pediatric vaccine, and adult vaccine) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

Chapter 4. Europe conjugate vaccine market
4.1. Regional market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
4.2. Segmentation based on disease indication (pneumococcal conugate vaccine [PCV], haemophilus influenzae type B [Hib] conjugate vaccine, diptheria and tetanus toxoids and pertussis [DTP] conjugate vaccine, meningococcal conjugate vaccine, and others) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
4.3. Segmentation based on end user (pediatric vaccine, and adult vaccine) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

Chapter 5. Asia-Pacific conjugate vaccine market
5.1. Regional market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
5.2. Segmentation based on disease indication (pneumococcal conugate vaccine [PCV], haemophilus influenzae type B [Hib] conjugate vaccine, diptheria and tetanus toxoids and pertussis [DTP] conjugate vaccine, meningococcal conjugate vaccine, and others) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
5.3. Segmentation based on end user (pediatric vaccine, and adult vaccine) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

Chapter 6. Latin America conjugate vaccine market
6.1. Regional market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
6.2. Segmentation based on disease indication (pneumococcal conugate vaccine [PCV], haemophilus influenzae type B [Hib] conjugate vaccine, diptheria and tetanus toxoids and pertussis [DTP] conjugate vaccine, meningococcal conjugate vaccine, and others) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
6.3. Segmentation based on end user (pediatric vaccine, and adult vaccine) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

Chapter 7. The Middle East and Africa conjugate vaccine market
7.1. Regional market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
7.2. Segmentation based on disease indication (pneumococcal conugate vaccine [PCV], haemophilus influenzae type B [Hib] conjugate vaccine, diptheria and tetanus toxoids and pertussis [DTP] conjugate vaccine, meningococcal conjugate vaccine, and others) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
7.3. Segmentation based on end user (pediatric vaccine, and adult vaccine) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

Chapter 8. Competitive landscape
8.1. GlaxoSmithKline
8.1.a. Company snapshot
8.1.b. Products/services
8.1.c. Major initiatives/highlights
8.1.d. Growth strategy
8.1.e. Geographical presence
8.1.f. Key numbers
Note: Similar information areas will be covered for the remaining competitors:
8.2. Pfizer Inc.
8.3. Merck & Co.
8.4. Novartis
8.5. Sanofi Pasteur
8.6. CSL Limited
8.7. Bharat Biotech International
8.8. Biological E Limited
8.9. Serum Institute of India

Chapter 9. Conclusion
9.1. Future outlook
Appendix
1. List of tables
2. Research methodology
3. Assumptions
4. About Netscribes Inc.
  • Global Encephalitis Vaccine Market Research Report 2019
    Published: 15-Mar-2019        Price: US 2900 Onwards        Pages: 97
    Encephalitis virus is a mosquito-borne Flavivirus and is transmitted via an enzootic cycle from mosquitoes to amplifying vertebrate hosts such as pigs and wading birds. It can easily be prevented using vaccines. It is the most common cause of encephalitis in Asia-Pacific. Encephalitis virus can easily be transmitted to humans through an infected mosquito bite and occurs primarily in rural agricultural areas. The global Encephalitis Vaccine market is valued at xx million US$......
  • 23-Valent Pneumococcal Polysaccharide Vaccine Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 13-Mar-2019        Price: US 3000 Onwards        Pages: 140
    23-Valent Pneumococcal Polysaccharide Vaccine Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global 23-Valent Pneumococcal Polysaccharide Vaccine industry with a focus on the Chinese market. The report provides key statistics on the market status of the 23-Valent Pneumococcal Polysaccharide Vaccine manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, ......
  • Global H1N1 Vaccines Market Research Report 2019
    Published: 13-Mar-2019        Price: US 2900 Onwards        Pages: 99
    A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The global H1N1 vaccination market is anticipated to boost in the focus period due to the rising cases of swine flu. Additionally, the rising geriatric population increases the risk of respiratory tract diseases, and immune deficient diseases, thus increasing the risk factor ......
  • Global Pneumococcal Polysaccharide Vaccine Market Research Report 2019
    Published: 11-Mar-2019        Price: US 2900 Onwards        Pages: 95
    Pneumococcal disease is an infection caused by the Streptococcus pneumoniae bacteria, which especially affects infants and children below 5 years of age. The major factors that contribute to the growth of the pneumococcal polysaccharide vaccine market include increasing prevalence of pneumonia globally, improving healthcare infrastructure, rise in government focus on immunization programs for pneumonia, and development of quality vaccines such as PPSV23.  The global Pneumoc......
  • Avian Influenza Vaccines Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 10-Mar-2019        Price: US 3000 Onwards        Pages: 147
    Avian Influenza Vaccines Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Avian Influenza Vaccines industry with a focus on the Chinese market. The report provides key statistics on the market status of the Avian Influenza Vaccines manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and......
  • Global Meningococcal Vaccines Market Status and Future Forecast 2015-2024
    Published: 08-Mar-2019        Price: US 4500 Onwards        Pages: 119
    Summary The report forecast global Meningococcal Vaccines market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2024. The report offers detailed coverage of Meningococcal Vaccines industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Meningococcal Vaccines by geography. The report splits the market size, by vol......
  • 2016-2024 World Meningococcal Vaccines Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 07-Mar-2019        Price: US 2800 Onwards        Pages: 103
    This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. Market Segment as follows: By Region / Countries - North America (U.S., Canada, Mexico) - Europe (Germany, U.K., France, Italy, Russia, Spain etc) - Asia-Pacific (China, India, Japan, Southeast Asia etc) - South Ame......
  • Global Encephalitis Vaccination Market Size, Status and Forecast 2019-2025
    Published: 07-Mar-2019        Price: US 3900 Onwards        Pages: 93
    Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito's classes. People and many animals may be infection source after infection Encephalitis virus. In 2018, the global Encephalitis Vaccination market size was xx million US$ and it is expected to reach......
  • Global Encephalitis Vaccination Market Status and Future Forecast 2015-2024
    Published: 05-Mar-2019        Price: US 4500 Onwards        Pages: 108
    Summary The report forecast global Encephalitis Vaccination market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2024. The report offers detailed coverage of Encephalitis Vaccination industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Encephalitis Vaccination by geography. The report splits the market size, ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs